On the venture investment front, Thomas Weisel Healthcare Venture Partners closed on a $53 million investment in Aspreva Pharmaceuticals, a company that identifies and develops new applications for existing medicines.
What does TWHVP stand for?
TWHVP stands for Thomas Weisel Healthcare Venture Partners (San Francisco, CA)
This definition appears rarely and is found in the following Acronym Finder categories:
- Business, finance, etc.
- Texas White Horse Ranch
- Tonight We Have Rhythm
- That's What He Said
- The Woodlands High School (Texas)
- Thomas Worthington High School (Ohio)
- Topeka West High School (Topeka, KS)
- Traditional Water Harvesting Systems
- Tunbridge Wells High School (Tunbridge Wells, Kent, UK)
- Thirsk White Horse Swim Team (UK)
- The World Has Turned & Left Me Here (Weezer song-title)
- T Wave Inversion (electrocardiography)
- Tactical Weather Intelligence
- Temporary Work Instruction (Australia)
- Terlato Wines International (Lake Bluff, IL)
- Texting While Intoxicated
- The Washington Independent
- The Way International (Christian ministry)
- The Welding Institute
- The Workplace, Inc. (Bridgeport, CT)
- The Writing Instructor (journal)
Samples in periodicals archive:
Bard, De Novo Ventures, DePuy/Johnson & Johnson, Earlybird Ventures, Edwards Lifesciences, Ethicon Endo-Surgery, Golden Gate Capital, Hospira, Integra LifeSciences, Medtronic, Johnson & Johnson, KeyBanc Capital Markets, Kimberly-Clark, Kobayashi Pharmaceuticals of America, Krauth Medical, Lighthouse Capital Partners, Matignon Technologies FCPR, Morgan Stanley, Musculoskeletal Transplant Foundation, NASDAQ, Novartis Pharma, Olympus America, Prospect Venture Partners, Rodman & Renshaw, Rothschild, Smith & Nephew, Sorin, Stryker, The Aurora Funds, Thomas Weisel Healthcare Venture Partners, Three Arch Partners, Triathlon Medical Ventures, Terumo, Wilson Sonsini, Goodrich & Rosati, and ZEVEX International.
On the venture capital front, the firm added Thomas Weisel Healthcare Venture Partners (TWHVP), a new $122 million fund to invest in biotechnology and medical device opportunities.
Jude Medical, Stryker, Thomas Weisel Healthcare Venture Partners, Triathlon Medical Ventures, Tyco Healthcare, US Army Medical Research & Material Command, U.
Vanguard Ventures, a leading, early-stage venture capital firm, led the round with participation from existing investors including Prospect Venture Partners, Skyline Venture Partners, Thomas Weisel Healthcare Venture Partners, De Novo Ventures and Sapient Capital.
Highland Capital Partners, Johnson & Johnson, Kimberly-Clark, Kyphon, McKinsey & Company, Medtronic Sofamor Danek, Morgan Stanley, Musculoskeletal Transplant Foundation, NuVasive, Olympus, Orthovita, Purdue Research Foundation, Regeneration Technologies, Stryker, SV Life Sciences, Synthes Spine, The Advisory Board Company, Thoma Cressey Equity Partners, Thomas Weisel Healthcare Venture Partners, TissueLink Medical, Viscogliosi Bros.
Interpore Cross International, Medtronic Sofamor Danek, Musculoskeletal Transplant Foundation, Nitinol Devices & Components/Johnson & Johnson, NuVasive, Orthofix, Orthovita, Osteotech, Regeneration Technologies, RiverVest Venture Partners, Smith & Nephew, Stryker, Synthes, Thoma Cressey Equity Partners, Thomas Weisel Healthcare Venture Partners, V.
Thomas Weisel Healthcare Venture Partners, a SpinalMotion founder and the lead investor in the company's Series A funding, also participated.